Literature DB >> 15615823

Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease.

Emilio D Poggio1, Xuelei Wang, Tom Greene, Frederik Van Lente, Phillip M Hall.   

Abstract

The performance of the Modification of Diet in Renal Disease (MDRD) and the Cockcroft-Gault (CG) equations as compared with measured (125)I-iothalamate GFR (iGFR) was analyzed in patients with chronic kidney disease (CKD) and in potential kidney donors. All outpatients (n = 1285) who underwent an iGFR between 1996 and 2003 were considered for analysis. Of these, 828 patients had CKD and 457 were potential kidney donors. Special emphasis was put on the calibration of the serum creatinine measurements. In CKD patients with GFR <60 ml/min per 1.73 m(2), the MDRD equation performed better than the CG formula with respect to bias (-0.5 versus 3.5 ml/min per 1.73 m(2), respectively) and accuracy within 30% (71 versus 60%, respectively) and 50% (89 versus 77%, respectively). Similar results are reported for 249 CKD patients with diabetes. In the kidney donor group, the MDRD equation significantly underestimated the measured GFR when compared with the CG formula, with a bias of -9.0 versus 1.9 ml/min per 1.73 m(2), respectively (P < 0.01), and both the MDRD and CG equations overestimated the strength of the association of GFR with measured serum creatinine. The present data add further validation of the MDRD equation in outpatients with moderate to advanced kidney disease as well as in those with diabetic nephropathy but suggest that its use is problematic in healthy individuals. This study also emphasizes the complexity of laboratory calibration of serum creatinine measurements, a determining factor when estimating GFR in both healthy individuals and CKD patients with preserved GFR.

Entities:  

Mesh:

Year:  2004        PMID: 15615823     DOI: 10.1681/ASN.2004060447

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  148 in total

1.  Chronic hepatitis C and chronic kidney disease.

Authors:  Jane C Tan
Journal:  Dig Dis Sci       Date:  2010-05       Impact factor: 3.199

2.  Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project.

Authors:  Jean W MacCluer; Marina Scavini; Vallabh O Shah; Shelley A Cole; Sandra L Laston; V Saroja Voruganti; Susan S Paine; Alfred J Eaton; Anthony G Comuzzie; Francesca Tentori; Dorothy R Pathak; Arlene Bobelu; Jeanette Bobelu; Donica Ghahate; Mildred Waikaniwa; Philip G Zager
Journal:  Am J Kidney Dis       Date:  2010-06-19       Impact factor: 8.860

3.  Measurement of renal function in a kidney donor: a comparison of creatinine-based and volume-based GFRs.

Authors:  Don Kyoung Choi; See Min Choi; Bong Hee Park; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Hyun Moo Lee; Han-Yong Choi; Hwang Gyun Jeon
Journal:  Eur Radiol       Date:  2015-05-08       Impact factor: 5.315

4.  Performance of the Japanese GFR equation in potential kidney donors.

Authors:  Masaru Horio; Yoshinari Yasuda; Jyunya Kaimori; Naotsugu Ichimaru; Yoshitaka Isaka; Shiro Takahara; Shinichi Nishi; Kazuharu Uchida; Asami Takeda; Ryohei Hattori; Hidehisa Kitada; Kazuhiko Tsuruya; Enyu Imai; Kota Takahashi; Tsuyoshi Watanabe; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2012-01-24       Impact factor: 2.801

5.  Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods.

Authors:  R J Macisaac; C Tsalamandris; M C Thomas; E Premaratne; S Panagiotopoulos; T J Smith; A Poon; M A Jenkins; S I Ratnaike; D A Power; G Jerums
Journal:  Diabetologia       Date:  2006-05-03       Impact factor: 10.122

6.  Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions.

Authors:  Andrew S Levey; Lesley A Stevens
Journal:  Am J Kidney Dis       Date:  2010-04       Impact factor: 8.860

7.  High-dose intravenous immunoglobulin pulse therapy in patients with progressive immunoglobulin A nephropathy: a long-term follow-up.

Authors:  F M Rasche; F Keller; P M Lepper; C Aymanns; W Karges; L-C Sailer; L von Müller; D Czock
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

8.  For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics.

Authors:  Andrew D Rule; Kent R Bailey; Gary L Schwartz; Sundeep Khosla; John C Lieske; L Joseph Melton
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

9.  The costs and benefits of automatic estimated glomerular filtration rate reporting.

Authors:  Julia R den Hartog; Peter P Reese; Borut Cizman; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

10.  Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999-2004.

Authors:  Jon J Snyder; Robert N Foley; Allan J Collins
Journal:  Am J Kidney Dis       Date:  2008-10-31       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.